Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06376331 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Washed Microbiota Transplantation for Attention-deficit/Hyperactivity Disorder

Study acronym: WMT for ADHD
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase changed: Phase 1 → not specified Show 4 more changesShow less
    • Eligibility criteria expanded, about 9 words
    • Secondary endpoints: details revised at 4 of 6 entries
    • Site details revised at 1 of 2 sites
    • Publications: details revised at 14 of 14 entries
  2. Primary endpoints: 2 to 1
    • Eligibility criteria shortened, about 6 words
    • Secondary endpoints: 5 to 6
    v6
  3. Eligibility criteria expanded, about 4 wordsv5
  4. Site details revised at 1 of 2 sitesv4
  5. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 20, 2024 to Apr 28, 2024
    • Site details revised at 2 of 2 sites
    v3
  6. Primary endpoints revised (2)
    • Secondary endpoints revised (5)
    • Study description shortened, about 1 word
    v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder characterized by inattention and hyperactivity-impulsivity. ADHD is often accompanied by oppositional defiant disorder and sleep disturbance, and can increase the risk of other psychiatric disorders, functional impairment in academic and occupational performance. Recently, gut microbiota has been implicated in the ADHD via gut-brain axis. In this study, investigators aimed to evaluate the efficacy of WMT for core ADHD symptoms and its comorbidities using specialized questionnaires for ADHD and investigate the underlying mechanism.
Trial Details
NCT Number NCT06376331
Lead Sponsor The Second Hospital of Nanjing Medical University
Collaborators: Nanjing Medical University
Conditions
(from sponsor)		 Attention-deficit/Hyperactivity Disorder
Related terms Attention Deficit Disorder with Hyperactivity, Parasomnias
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov